Tova Chajek

Title: Tova Chajek: Innovator in Therapeutic Lipoprotein Compositions

Introduction

Tova Chajek is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of therapeutic lipoprotein compositions, holding a total of 3 patents. Her work focuses on innovative methods to address health issues related to elevated serum lipoprotein levels.

Latest Patents

Chajek's latest patents include groundbreaking advancements in therapeutic lipoprotein compositions. One of her notable inventions is a lipoprotein particle that consists essentially of lecithin phospholipids with low phase transition temperatures and human apoproteins A and C. This therapeutic composition is designed for administration to subjects suffering from conditions associated with elevated serum Lp(a) levels, hypertension, and acute renal failure. Another significant patent involves a method for reducing serum lipoprotein (A) concentration through the administration of liposomes. This method utilizes a suspension of small, unilamellar vesicles composed primarily of phosphatidylcholine phospholipids, which are infused over time to achieve a significant drop in serum Lp(a) concentration.

Career Highlights

Tova Chajek is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this esteemed institution has allowed her to explore and develop innovative solutions in the field of therapeutic lipoproteins.

Collaborations

Chajek has collaborated with notable colleagues, including Yechezkel Barenholz and Hilary Shmeeda, who have contributed to her research endeavors.

Conclusion

Tova Chajek's innovative work in therapeutic lipoprotein compositions showcases her dedication to advancing medical science. Her patents reflect her commitment to addressing critical health issues, making her a significant figure in the field of biomedical research.